Today Exiqon Announces the First Two Centers of Excellence – Bioneer and TATAA

Exiqon A/S (NASDAQ OMX: EXQ.CO), a leading supplier of high-value gene expression analysis products, today announced the appointment of two Centers of Excellence as part of its new partnership program. The Center of Excellence partnership program is introduced in response to an increased demand for Exiqon’s products and services.

TATAA Biocenter (www.tataa.com) will market qPCR services based on the Exiqon microRNA LNA™ qPCR product line and Bioneer A/S (www.bioneer.dk) will market In-situ Hybridization services based on the Exiqon LNA™ microRNA and mRNA Detection product line.

“We are pleased to announce the first two Centers of Excellence in our Partnership program”, said Henrik M Pfundheller, Ph.D., SVP Sales & Marketing and added: “TATAA and Bioneer are both considered experts within their respective fields and we are proud to include these two centers in our new Partnership program”.

Exiqon plans to announce additional Centers of Excellence in the up-coming months

< | >